Abbott Labs Sues Zydus Over Depakote
Abbott Laboratories has filed another patent suit to protect the billion-dollar U.S. market for the bipolar mania and epilepsy treatment Depakote, accusing Zydus Pharmaceuticals (USA) Inc. of infringing four patents related...To view the full article, register now.
Already a subscriber? Click here to view full article